IFI-M · SB Tissue-Specific Series

Specimen SS-F-M2-07706 // MULTI-AXIS · IFI-M

SB Tissue-Specific Series III-AG-B

Stevia rebaudiana

Stevia

Tier IIISB Tissue-Specific Series

Target Trait

2.18×

fold-change

Sweet+Bitter-Attenuation tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-07706

Genomic Edits

8

GC Content

45.6%

Construct Length

4,335 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TAS1R2/TAS1R3 + TAS2R38 (suppression)

IFI Score

218

Pathway Edits

  • TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized S+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-S and IFI-B pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Sweet-Bitter-Attenuation combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for S+B simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized SB spatial patterning
  • Protein scaffold engineering for S+B enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized TAS1R2/TAS1R3 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous sweet and bitter-attenuation accumulation without competing pathway suppressionTissue-specific dual expression for SB multi-axis integrationT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III SB dual-axis tissue-specific platform for food ingredient applications requiring verified combined sweet+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$1549 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities